AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $45,000 | -79.4% | 1,281 | -68.6% | 0.00% | -83.3% |
| Q2 2020 | $218,000 | +2322.2% | 4,085 | +2817.9% | 0.01% | +1100.0% |
| Q1 2019 | $9,000 | -98.3% | 140 | -97.9% | 0.00% | -96.7% |
| Q3 2018 | $517,000 | +15.7% | 6,701 | +26.4% | 0.03% | +7.1% |
| Q2 2018 | $447,000 | +3625.0% | 5,301 | +3457.7% | 0.03% | +2700.0% |
| Q1 2018 | $12,000 | -95.7% | 149 | -96.5% | 0.00% | -96.0% |
| Q3 2017 | $281,000 | +57.0% | 4,215 | +21.3% | 0.02% | +47.1% |
| Q2 2017 | $179,000 | -47.0% | 3,476 | +15.4% | 0.02% | -66.0% |
| Q4 2014 | $338,000 | – | 3,013 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |